Kaminsky A, Florez-White M, Arias MI, Bagatin E

Language: Spanish
References: 25
Page: 18-23
PDF size: 390.58 Kb.

ABSTRACT

Acne is the most common chronic skin disease among young people, and it is one of the most frequent causes of dermatological consultation. Many classifications of acne are known; some simple and others more complex and difficult to understand. The Ibero-Latin American Group on Acne Study (GILEA) –Chapter of acne, rosacea, and related conditions, from the Ibero-Latin American College of Dermatology (CILAD)– is composed by renowned dermatologists, specialists in acne, from most countries of Latin America and the Iberian Peninsula. Since its inception in 2004, the group has been working on a classification that seeks to associate the concepts of age, clinical form and severity, as well as a treatment algorithm based on this classification. The result was the first version that was published in 2012 in the second edition of Acné. Un enfoque global (Acne; a global approach), and the classification presented here is a new version (2014) with slight modifications over the previous consensus and the result of consultations among the members of GILEA. The authors consider that this classification will provide a new basis for addressing clinical, epidemiological and therapeutic studies. Nevertheless, like any other medical concept, it is open to future changes resulting from the advances in science.

REFERENCES

1. Gollnick HP, Finlay AY, Shear N. Global Alliance to Improve Outcomes in Acne. Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol. 2008; 9: 279-284.

2. Bloch B. Metabolism, endocrine glands and skin diseases with special reference to acne vulgaris and xanthoma. Br J Dermatol. 1931; 43: 77-87.

3. Pillsbury DM, Zilmerman MC, Baldridge GD. Experimental control in clinical investigation. J Invest Dermatol. 1950; 14: 359-371.

4. Plewig G, Kligman AM. Classification of acne. Cutis. 1976; 17: 520-522.

5. Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Arch Dermatol. 1979; 115: 571-575.

6. Cunliffe WJ. Clinical assessment of acne vulgaris. In: Cunliffe WJ. Acne. London: Martin Dunitz; 1989: pp. 115-122.

7. Allen BS, Smith JG Jr. Various parameters for grading acne vulgaris. Arch Dermatol. 1982; 118: 23-25.

8. Burke BM, Cunliffe WJ. The assessment of acne vulgaris –Leeds technique. Br J Dermatol. 1984; 111: 83-92.

9. Pochi PE, Shalita AR, Strauss JS, Webster SB, Cunliffe WJ, Katz HI et al. Report of the consensus conference on acne classification. Washington, DC, March 24-25, 1990. J Am Acad Dermatol. 1991; 24: 495-500.

10. White GM. Recent findings in the epidemiologic evidence, classification and subtypes of acne vulgaris. J Am Acad Dermatol. 1998; 39: 534-537.

11. O’Brian SC, Levis JB, Cunliffe WJ. Leeds revised acne grading system. J Dermatol Treatment. 1998; 9: 215-220.

12. Cunliffe WJ, Gollnick H. Clinical features of acne. In: Cunliffe WJ, Gollnick H. Acne. Diagnosis and managment. London: Martin Dunitz; 2001: pp. 49-67.

13. Ramos e Silva M, Costantini S. Clasificación, formas clínicas y variantes. En: Kaminsky A. Acné. Un enfoque global. GLEA. Buenos Aires: Colegio Ibero-Latinoamericano de Dermatología; 2007: pp. 47-56.

14. Kaminsky A, Florez-White M. Clasificación. En: Kaminsky A, Florez-White M. Acné. Un enfoque global. Buenos Aires: Alfaomega Grupo Editor S.A. Colegio Ibero-Latinoamericano de Dermatología (CILAD); 2012: pp. 59-62.

15. Kaminsky A, Ramos e Silva M, Costantini S. Erupciones acneiformes. En: Kaminsky A, Florez-White M. Acné. Un enfoque global. Buenos Aires: Alfaomega Grupo Editor S.A. Colegio Ibero-Latinoamericano de Dermatología (CILAD); 2012: pp. 83-92.

16. Zanelato TP, Gontijo GM, Alves CA, Pinto JC, Cunha PR. Disabling acne fulminans. An Bras Dermatol. 2011; 86 (4 Suppl. 1): S9-12.

17. Benhamou C, Chamot AM, Kahn MF. Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome. Ann Dermatol Venereol. 1988; 115: 613-618.

18. Zhao Z, Li Y, Zhao H, Li H. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work. J Dermatol. 2011; 38: 155-159.

19. Dellatorre G, Castro CC. Do you know this syndrome? An Bras Dermatol. 2012; 87: 155-156.

20. Kaminsky A. Sindrome de oclusão folículos pilosos. En: Ramos-e-Silva, Castro MCR. Fundamentos de Dermatologia. Rio de Janeiro: Editota Atheneu; 2009: pp. 843-849.

21. Rosner IA, Burg CG, Wisnieski JJ, Schacter BZ, Richter DE. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. J Rheumatol. 1993; 20: 684-687.

22. Lindor N, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997; 72: 611-615.

23. Wise C, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Human Molecular Genetics. 2002; 11: 961-969.

24. Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML et al. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum. 2012; 64: 2022-2027.

25. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012; 66: 409-415.